Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $2,500 | 1 | 99.2% |
| Food and Beverage | $19.57 | 1 | 0.8% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $2,500 | 1 | $0 (2018) |
| Ceribell, Inc. | $19.57 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19.57 | 1 | Ceribell, Inc. ($19.57) |
| 2018 | $2,500 | 1 | Merck Sharp & Dohme Corporation ($2,500) |
All Payment Transactions
2 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | Ceribell, Inc. | POCKET EEG DEVICE (Device) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Neurology | ||||||
| 03/05/2018 | Merck Sharp & Dohme Corporation | DULERA (Drug) | — | Cash or cash equivalent | $2,500.00 | Research |
| Study: A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate,Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma Protocol No. P06241 also known as P202 • Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A 26-Week Randomized, Double-Blinded, Active Controlled Study Comparing the Safety of Mometasone Furoate,Formoterol Fumarate MDI Fixed Dose Combination Versus Mometasone Furoate MDI Monotherapy in Adolescents and Adults With Persistent Asthma Protocol No. P06241 also known as P202 | Merck Sharp & Dohme Corporation | $2,500 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 1,033 | 1,237 | $1.1M | $135,529 |
| 2022 | 10 | 1,056 | 1,307 | $1.1M | $148,802 |
| 2021 | 10 | 1,013 | 1,168 | $1.0M | $144,343 |
| 2020 | 10 | 1,069 | 1,273 | $1.1M | $159,522 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 15 | 15 | $14,732 | $1,653 | 11.2% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Facility | 2021 | 13 | 13 | $4,928 | $782.60 | 15.9% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older, not tunneled | Facility | 2021 | 11 | 11 | $9,343 | $720.83 | 7.7% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 12 | 12 | $2,765 | $553.83 | 20.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 600 | 645 | $759,247 | $99,688 | 13.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 132 | 135 | $146,847 | $19,067 | 13.0% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 119 | 209 | $51,941 | $16,735 | 32.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 45 | 50 | $73,716 | $8,625 | 11.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 71 | 129 | $22,430 | $7,117 | 31.7% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 21 | 23 | $23,517 | $2,580 | 11.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 30 | 30 | $6,980 | $2,411 | 34.5% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 28 | 28 | $5,254 | $1,573 | 29.9% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2020 | 12 | 13 | $4,022 | $990.55 | 24.6% |
| 36556 | Insertion of central venous catheter for infusion, patient 5 years or older | Facility | 2020 | 11 | 11 | $9,617 | $737.82 | 7.7% |
About Dr. Robert Walker, M.D
Dr. Robert Walker, M.D is a Internal Medicine healthcare provider based in Greenville, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1659320943.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Walker, M.D has received a total of $2,520 in payments from pharmaceutical and medical device companies, with $19.57 received in 2024. These payments were reported across 2 transactions from 2 companies. The most common payment nature is "" ($2,500).
As a Medicare-enrolled provider, Walker has provided services to 4,171 Medicare beneficiaries, totaling 4,985 services with total Medicare billing of $588,197. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Greenville, SC
- Active Since 05/06/2006
- Last Updated 06/22/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659320943
Products in Payments
- DULERA (Drug) $2,500
- POCKET EEG DEVICE (Device) $19.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Greenville
Stephen Dyar, Md, MD
Internal Medicine — Payments: $381,835
Dr. John Catanzaro, Md, MD
Internal Medicine — Payments: $331,996
Bhumika Patel, M.d, M.D
Internal Medicine — Payments: $208,547
Dr. Thomas Gallaher, M.d, M.D
Internal Medicine — Payments: $208,355
Bruce Gray, D.o, D.O
Internal Medicine — Payments: $166,102
Dr. Mark Purcell, Do, DO
Internal Medicine — Payments: $135,587